Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj K Puri

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Journal of Neuro-Oncology|December 3, 2003
Introduction to special issue: targeted toxins for glioma therapyRaj K Puri
Journal of Neuro-Oncology|November 24, 2017
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiformeJing Han, Raj K Puri
Protein Expression and Purification|January 12, 2005
Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coliBharat H Joshi, Raj K Puri
Current Molecular Medicine|August 20, 2009
Tumor immunologyBharat H Joshi, Raj K Puri
Immunotherapy|July 20, 2010
IL-13 receptor-alpha2: a novel target for cancer therapyBharat H Joshi, Raj K Puri
Journal of Neuro-Oncology|December 3, 2003
Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedsideSyed R Husain, Raj K Puri
Journal of Translational Medicine|March 31, 2010
Cell and gene therapies: moving from research to clinicDavid F Stroncek, Raj K Puri
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancerKoji Kawakami, Mariko Kawakami, Raj K Puri
Molecular Cancer Therapeutics|June 21, 2008
Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxinMitomu Kioi, Saraswathy Seetharam, Raj K Puri
Cellular Immunology|August 28, 2004
Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4RMitomu Kioi, Koji Kawakami, Raj K Puri
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Journal of Neuro-Oncology|December 3, 2003
Introduction to special issue: targeted toxins for glioma therapyRaj K Puri
Journal of Neuro-Oncology|November 24, 2017
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiformeJing Han, Raj K Puri
Protein Expression and Purification|January 12, 2005
Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coliBharat H Joshi, Raj K Puri
Current Molecular Medicine|August 20, 2009
Tumor immunologyBharat H Joshi, Raj K Puri
Immunotherapy|July 20, 2010
IL-13 receptor-alpha2: a novel target for cancer therapyBharat H Joshi, Raj K Puri
Journal of Neuro-Oncology|December 3, 2003
Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedsideSyed R Husain, Raj K Puri
Journal of Translational Medicine|March 31, 2010
Cell and gene therapies: moving from research to clinicDavid F Stroncek, Raj K Puri
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancerKoji Kawakami, Mariko Kawakami, Raj K Puri
Molecular Cancer Therapeutics|June 21, 2008
Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxinMitomu Kioi, Saraswathy Seetharam, Raj K Puri
Cellular Immunology|August 28, 2004
Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4RMitomu Kioi, Koji Kawakami, Raj K Puri
Pageof 17